Dolsten Mikael 4
4 · ROCKET PHARMACEUTICALS, INC. · Filed Sep 11, 2024
Insider Transaction Report
Form 4
Dolsten Mikael
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-09-09+27,545→ 27,545 totalExercise: $19.73Exp: 2034-09-09→ Common Stock (27,545 underlying) - Award
Stock Option (Right to Buy)
2024-09-09+22,988→ 22,988 totalExercise: $19.73Exp: 2034-09-09→ Common Stock (22,988 underlying)
Footnotes (2)
- [F1]This option represents a right to purchase a total of 27,545 shares of the Issuer's common stock, which will vest in equal monthly installments over a three-year period, such that all of the shares underlying this option will be fully vested on September 9, 2027.
- [F2]This option represents a right to purchase a total of 22,988 shares of the Issuer's common stock, which will fully vest on September 9, 2025.